Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670011 | SCV000794819 | likely pathogenic | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-10-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855532 | SCV002154864 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2021-06-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 554388). This variant has not been reported in the literature in individuals affected with PEX12-related conditions. This variant is present in population databases (rs765404768, ExAC 0.002%). This sequence change creates a premature translational stop signal (p.Tyr74*) in the PEX12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX12 are known to be pathogenic (PMID: 9090384, 9632816, 21031596). |